Trends of Axillary Treatment in Sentinel Node-Positive Breast Cancer Patients Undergoing Mastectomy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Trends of Axillary Treatment in Sentinel Node-Positive Breast Cancer Patients Undergoing Mastectomy ; volume:30 ; number:9 ; day:24 ; month:5 ; year:2023 ; pages:5623-5632 ; date:9.2023
Annals of surgical oncology ; 30, Heft 9 (24.5.2023), 5623-5632, 9.2023
- Urheber
-
Verreck, Eline E. F.
Steenhoven, Julia E. C. van
Kuijer, Anne
Maaren, Marissa C. van
Simons, Janine M.
Siesling, Sabine
Dalen, Thijs van
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1245/s10434-023-13568-3
- URN
-
urn:nbn:de:101:1-2023110208465667422343
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Verreck, Eline E. F.
- Steenhoven, Julia E. C. van
- Kuijer, Anne
- Maaren, Marissa C. van
- Simons, Janine M.
- Siesling, Sabine
- Dalen, Thijs van
- SpringerLink (Online service)
Ähnliche Objekte (12)
ASO Author Reflections: Trends of Axillary Treatment in Sentinel Node-Positive Breast Cancer Patients Undergoing Mastectomy
Oncological Safety of Skipping Axillary Lymph Node Dissection in Patients with Clinical N0, Sentinel Node-Positive Breast Cancer Undergoing Total Mastectomy
Different outcome in node-positive breast cancer patients found by axillary ultrasound or sentinel node procedure
Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial
Prediction of non-sentinel lymph node metastases in T1–2 sentinel lymph node-positive breast cancer patients undergoing mastectomy following neoadjuvant therapy
Internal Mammary Sentinel Lymph Node Biopsy in Clinically Axillary Lymph Node-Positive Breast Cancer: Diagnosis and Implications for Patient Management
Axillary surgery in women with sentinel node-positive operable breast cancer: a systematic review with meta-analyses
Efficacy and safety comparison between axillary lymph node dissection with no axillary surgery in patients with sentinel node-positive breast cancer: a systematic review and meta-analysis
Axillary staging after neoadjuvant chemotherapy for initially node-positive breast carcinoma in germany
De-Escalating Axillary Surgery in Node-Positive Breast Cancer Treated with Neoadjuvant Systemic Therapy
Fat-enlarged axillary lymph nodes are associated with node-positive breast cancer in obese patients
Minimize the extent and morbidity of axillary dissection for node-positive breast cancer patients: implementation of axillary lymph node dissection based on breast lymphatics level
ASO Author Reflections: Trends of Axillary Treatment in Sentinel Node-Positive Breast Cancer Patients Undergoing Mastectomy
Oncological Safety of Skipping Axillary Lymph Node Dissection in Patients with Clinical N0, Sentinel Node-Positive Breast Cancer Undergoing Total Mastectomy
Different outcome in node-positive breast cancer patients found by axillary ultrasound or sentinel node procedure
Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial
Prediction of non-sentinel lymph node metastases in T1–2 sentinel lymph node-positive breast cancer patients undergoing mastectomy following neoadjuvant therapy
Internal Mammary Sentinel Lymph Node Biopsy in Clinically Axillary Lymph Node-Positive Breast Cancer: Diagnosis and Implications for Patient Management
Axillary surgery in women with sentinel node-positive operable breast cancer: a systematic review with meta-analyses
Efficacy and safety comparison between axillary lymph node dissection with no axillary surgery in patients with sentinel node-positive breast cancer: a systematic review and meta-analysis
Axillary staging after neoadjuvant chemotherapy for initially node-positive breast carcinoma in germany
De-Escalating Axillary Surgery in Node-Positive Breast Cancer Treated with Neoadjuvant Systemic Therapy
Fat-enlarged axillary lymph nodes are associated with node-positive breast cancer in obese patients
Minimize the extent and morbidity of axillary dissection for node-positive breast cancer patients: implementation of axillary lymph node dissection based on breast lymphatics level
ASO Author Reflections: Trends of Axillary Treatment in Sentinel Node-Positive Breast Cancer Patients Undergoing Mastectomy
Oncological Safety of Skipping Axillary Lymph Node Dissection in Patients with Clinical N0, Sentinel Node-Positive Breast Cancer Undergoing Total Mastectomy
Different outcome in node-positive breast cancer patients found by axillary ultrasound or sentinel node procedure
Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial
Prediction of non-sentinel lymph node metastases in T1–2 sentinel lymph node-positive breast cancer patients undergoing mastectomy following neoadjuvant therapy
Internal Mammary Sentinel Lymph Node Biopsy in Clinically Axillary Lymph Node-Positive Breast Cancer: Diagnosis and Implications for Patient Management
Axillary surgery in women with sentinel node-positive operable breast cancer: a systematic review with meta-analyses
Efficacy and safety comparison between axillary lymph node dissection with no axillary surgery in patients with sentinel node-positive breast cancer: a systematic review and meta-analysis
Axillary staging after neoadjuvant chemotherapy for initially node-positive breast carcinoma in germany
De-Escalating Axillary Surgery in Node-Positive Breast Cancer Treated with Neoadjuvant Systemic Therapy
Fat-enlarged axillary lymph nodes are associated with node-positive breast cancer in obese patients